These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

207 related items for PubMed ID: 7608212

  • 1. Identification of tuberin, the tuberous sclerosis-2 product. Tuberin possesses specific Rap1GAP activity.
    Wienecke R, König A, DeClue JE.
    J Biol Chem; 1995 Jul 07; 270(27):16409-14. PubMed ID: 7608212
    [Abstract] [Full Text] [Related]

  • 2. The tuberous sclerosis 2 gene product, tuberin, functions as a Rab5 GTPase activating protein (GAP) in modulating endocytosis.
    Xiao GH, Shoarinejad F, Jin F, Golemis EA, Yeung RS.
    J Biol Chem; 1997 Mar 07; 272(10):6097-100. PubMed ID: 9045618
    [Abstract] [Full Text] [Related]

  • 3. The GAP-related domain of tuberin, the product of the TSC2 gene, is a target for missense mutations in tuberous sclerosis.
    Maheshwar MM, Cheadle JP, Jones AC, Myring J, Fryer AE, Harris PC, Sampson JR.
    Hum Mol Genet; 1997 Oct 07; 6(11):1991-6. PubMed ID: 9302281
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Reduction of expression of tuberin, the tuberous-sclerosis-complex-gene-2 product in tuberous sclerosis complex associated connective tissue nevi and sporadic squamous and basal cell carcinomas.
    Wienecke R, Klemm E, Karparti S, Swanson NA, Green AJ, DeClue JE.
    J Cutan Pathol; 2002 May 07; 29(5):287-90. PubMed ID: 12100629
    [Abstract] [Full Text] [Related]

  • 6. Interaction between hamartin and tuberin, the TSC1 and TSC2 gene products.
    van Slegtenhorst M, Nellist M, Nagelkerken B, Cheadle J, Snell R, van den Ouweland A, Reuser A, Sampson J, Halley D, van der Sluijs P.
    Hum Mol Genet; 1998 Jun 07; 7(6):1053-7. PubMed ID: 9580671
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Co-localization of the TSC2 product tuberin with its target Rap1 in the Golgi apparatus.
    Wienecke R, Maize JC, Shoarinejad F, Vass WC, Reed J, Bonifacino JS, Resau JH, de Gunzburg J, Yeung RS, DeClue JE.
    Oncogene; 1996 Sep 05; 13(5):913-23. PubMed ID: 8806680
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Pathological mutations in TSC1 and TSC2 disrupt the interaction between hamartin and tuberin.
    Hodges AK, Li S, Maynard J, Parry L, Braverman R, Cheadle JP, DeClue JE, Sampson JR.
    Hum Mol Genet; 2001 Dec 01; 10(25):2899-905. PubMed ID: 11741833
    [Abstract] [Full Text] [Related]

  • 11. Characterization of the cytosolic tuberin-hamartin complex. Tuberin is a cytosolic chaperone for hamartin.
    Nellist M, van Slegtenhorst MA, Goedbloed M, van den Ouweland AM, Halley DJ, van der Sluijs P.
    J Biol Chem; 1999 Dec 10; 274(50):35647-52. PubMed ID: 10585443
    [Abstract] [Full Text] [Related]

  • 12. Expression of the tuberous sclerosis 2 gene product, tuberin, in adult and developing nervous system tissues.
    Geist RT, Reddy AJ, Zhang J, Gutmann DH.
    Neurobiol Dis; 1996 Apr 10; 3(2):111-20. PubMed ID: 9173918
    [Abstract] [Full Text] [Related]

  • 13. Role of the tuberous sclerosis gene-2 product in cell cycle control. Loss of the tuberous sclerosis gene-2 induces quiescent cells to enter S phase.
    Soucek T, Pusch O, Wienecke R, DeClue JE, Hengstschläger M.
    J Biol Chem; 1997 Nov 14; 272(46):29301-8. PubMed ID: 9361010
    [Abstract] [Full Text] [Related]

  • 14. Co-localization of TSC1 and TSC2 gene products in tubers of patients with tuberous sclerosis.
    Johnson MW, Emelin JK, Park SH, Vinters HV.
    Brain Pathol; 1999 Jan 14; 9(1):45-54. PubMed ID: 9989450
    [Abstract] [Full Text] [Related]

  • 15. Tuberin, the tuberous sclerosis complex 2 tumor suppressor gene product, regulates Rho activation, cell adhesion and migration.
    Astrinidis A, Cash TP, Hunter DS, Walker CL, Chernoff J, Henske EP.
    Oncogene; 2002 Dec 05; 21(55):8470-6. PubMed ID: 12466966
    [Abstract] [Full Text] [Related]

  • 16. TSC2 missense mutations inhibit tuberin phosphorylation and prevent formation of the tuberin-hamartin complex.
    Nellist M, Verhaaf B, Goedbloed MA, Reuser AJ, van den Ouweland AM, Halley DJ.
    Hum Mol Genet; 2001 Dec 01; 10(25):2889-98. PubMed ID: 11741832
    [Abstract] [Full Text] [Related]

  • 17. Tuberin phosphorylation regulates its interaction with hamartin. Two proteins involved in tuberous sclerosis.
    Aicher LD, Campbell JS, Yeung RS.
    J Biol Chem; 2001 Jun 15; 276(24):21017-21. PubMed ID: 11290735
    [Abstract] [Full Text] [Related]

  • 18. Tuberous sclerosis complex: genetics to pathogenesis.
    Narayanan V.
    Pediatr Neurol; 2003 Nov 15; 29(5):404-9. PubMed ID: 14684235
    [Abstract] [Full Text] [Related]

  • 19. Tuberous sclerosis: immunohistochemistry expression of tuberin and hamartin in a 31-week gestational fetus.
    Vinaitheerthan M, Wei J, Mizuguchi M, Greco A, Barness EG.
    Fetal Pediatr Pathol; 2004 Nov 15; 23(4):241-9. PubMed ID: 16095035
    [Abstract] [Full Text] [Related]

  • 20. Structure of the Tuberous Sclerosis Complex 2 (TSC2) N Terminus Provides Insight into Complex Assembly and Tuberous Sclerosis Pathogenesis.
    Zech R, Kiontke S, Mueller U, Oeckinghaus A, Kümmel D.
    J Biol Chem; 2016 Sep 16; 291(38):20008-20. PubMed ID: 27493206
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.